Haier Pharmaceutical

Qingdao Haier Pharmaceutical, a core subsidiary of the Haier Group, is a specialized pharmaceutical company focused on the research and production of treatments for bone and mineral metabolism. The company is widely recognized in the Chinese market for its flagship brand 'Tiandi,' which produces Alfacalcidol soft capsules used to treat osteoporosis and renal bone disease. In addition to bone health, the firm manufactures and markets products for cardiovascular diseases and digestive health. Operating under the umbrella of the global Haier conglomerate, the company utilizes modern GMP-certified facilities to maintain a significant domestic footprint in metabolic disease management.